MOLECULAR TARGETING TECHNOLOGIES, INC.

West Chester, PA · Biotech · Private

Synthetic lipid nanoparticles (DPA-exposing liposomes) that selectively bind procoagulant phosphatidylserine on activated platelets and extracellular vesicles to reduce thrombosis while minimizing ble

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · mtarget.com

Sector: Biotech
Headquarters: West Chester, PA
Total capital: $4.6M

Federal grants: $4M; 7 awards · 2015–2023; Rank in peer group#234 of 514
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $573K; 2 awards · Health and Human S; Rank in Biotech#222 of 4373
Granted patents: 3; 13 pending · first 2015; Rank in peer group#109 of 514

Capital timeline

Latest events

Jul 2023Federal grantHealth and Human S · Phase II · Instantaneous Tumor Spray for Real-Time Surgical Guidance$999K
Feb 2023Federal grantHealth and Human S · Phase I · Phosphatidylserine-blocking nanoparticles as improved anti-thrombotic with reduced bleeding risk$300K
Sep 2022Federal grantHealth and Human S · Phase II · Instantaneous Tumor Spray for Real-Time Surgical Guidance$2M
Feb 2019Federal grantHealth and Human S · Phase I · Sprayable, Prompt Color Changing Dye to Delineate Ovarian Cancer During Surgery$24K
Apr 2018Federal grantHealth and Human S · Phase I · Sprayable, Prompt Color Changing Dye to Delineate Ovarian Cancer During Surgery$253K
Sep 2017Federal contractHealth and Human S · Igf::ot::igf This Project Will Provide A Cancer-selective, Phosphatidylserine (ps)-targeted Radiolabeled Nanovesicle System For Targeted Radionuclide Therapy (trt) Of Brain Tumors.$350K
Jul 2017Federal grantHealth and Human S · Phase I · Topical Drug Treatment of Cutaneous Leishmaniasis$214K

Show 2 earlier federal awards

Mar 2015Federal grantHealth and Human S · Phase I · A PE-specific SPECT probe for the early detection of cancer treatment-induced cardiotoxicity.$225K
Sep 2014Federal contractHealth and Human S · Igf::ot::igf SBIR Topic 85 To Support The Development Of Target Specific Molecular Imaging Agents In Combination With Existing Imaging Modalities To Detect High Risk Atherosclerotic Plaque.$223K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grants#234 · top 46%
Granted patents#109 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 16

Sep 28, 2023PendingCompounds And Compositions For Tumor Detection And Surgical GuidanceUSPTOApplication 18041532
Apr 20, 2023PendingCompounds And Compositions For Retinal Injury Detection And Methods Of Using SameUSPTOApplication 17759912
Aug 17, 2021GrantedAnti-thrombotic Agents and Methods of Use ThereofUSPTOUS 11,090,309

Show all 16 patent records

Compounds And Compositions For Tumor Detection And Surgical GuidanceSep 28, 2023 · Application 18041532Pending
Compounds And Compositions For Retinal Injury Detection And Methods Of Using SameApr 20, 2023 · Application 17759912Pending
Anti-thrombotic Agents and Methods of Use ThereofAug 17, 2021 · US 11,090,309Granted
Dipicolylamine Derivatives And Their Pharmaceutical UsesJul 12, 2016 · US 9,388,193Granted
Compositions And Methods Of Diagnosing Ocular DiseasesDec 24, 2015 · Application 14650995Pending
Molecular Probes For Multimodality Imaging Of Anionic Membrane SurfacesDec 15, 2015 · US 9,211,349Granted
Anti-thrombotic Agents And Methods Of Use ThereofApplication PCTUS2018040551Pending
Zn(II)-bis-dipicolylamine-Containing Liposomes Are An Anti-thrombotic AgentApplication 62527194Pending
Compounds And Compositions For Tumor Detection And Surgical GuidanceApplication 63066072Pending
Compounds And Compositions For Tumor Detection And Surgical GuidanceApplication PCTUS2021046181Pending
Dipicolyamine Derivatives And Their Pharmaceutical UsesApplication 62001725Pending
Compositions And Methods Of Diagnosing Ocular DiseasesApplication PCTUS2013071136Pending
Molecular Probes For Multimodality Imaging Of Anionic Membrane SurfacesApplication PCTUS2013044108Pending
High Performance Luminescent CompoundsApplication PCTUS2009064621Pending
Compounds And Compositions For Retinal Injury Detection And Methods Of Using SameApplication PCTUS2020016846Pending
TECHNETIUM-99M Glucarate Methods Of Use For Monitoring TissuesApplication PCTUS2004036408Pending

TENDEL THERAPIES INCSimilar federal contract value in Biotech · $600K in contracts
EVIMERO, LLCSimilar federal contract value in Biotech · $597K in contracts
Protein Innovation Labs, Inc.Similar federal contract value in Biotech · $586K in contracts
TERA-PRINT LLCSimilar federal contract value in Biotech · $569K in contracts
ABTERRA BIOSCIENCES, INC.Similar federal contract value in Biotech · $556K in contracts
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALSSimilar federal contract value in Biotech · $550K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.